Bone Biologics Corp. (BBLG)
0.5615
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
0.5615
0.00 (0.00%)
After-Hours: 16:29
Bone Biologics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.8441 |
| June 30, 2021 | -0.8546 |
| March 31, 2021 | -0.8441 |
| December 31, 2020 | -0.8562 |
| September 30, 2020 | -0.8762 |
| June 30, 2020 | -0.8973 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.9185 |
| December 31, 2019 | -0.9539 |
| September 30, 2019 | -0.984 |
| June 30, 2019 | -0.9857 |
| March 31, 2019 | -0.9728 |
| December 31, 2018 | -1.047 |
| September 30, 2018 | -1.254 |
| June 30, 2018 | -0.969 |
| March 31, 2018 | -0.9838 |
| December 31, 2017 | -0.9802 |
| September 30, 2017 | -0.9253 |
| June 30, 2017 | -0.8774 |
| March 31, 2017 | -0.9872 |
| December 31, 2016 | -1.048 |
| September 30, 2016 | -0.8459 |
| June 30, 2016 | -1.062 |
| March 31, 2016 | -1.768 |
| December 31, 2015 | -0.9886 |
| September 30, 2015 | -2.475 |
| June 30, 2015 | -5.865 |
| March 31, 2015 | |
| December 31, 2014 | -1.975 |
| September 30, 2014 | -0.7321 |
| June 30, 2014 | -0.705 |
| January 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.437M |
| Total Liabilities (Quarterly) | 0.512M |
| Shareholders Equity (Quarterly) | 3.925M |
| Current Ratio | 8.665 |